CVS Lowering Price of Generic EpiPen

News
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

 

**Embargo: Cleveland-Akron, OH** Cigna, a top health insurer, is dropping coverage of the EpiPen. The lifesaving allergy medication has been a flash point for debates over rising drug costs. Manufacturer Mylan (MYL) jacked up the price of the EpiPen by more than 400% since 2009, and was forced to develop a generic alternative amid national outrage.
FILE: EpiPen

NEW YORK — CVS is cutting the price on a generic version of the EpiPen allergy treatment.

The drugstore chain announced Thursday that it will sell a generic version of Impax Laboratories’ Adrenaclick treatment for $109.99 per two-pack, down from $200.

The drug company Mylan drew the ire of customers and Congress when it raised the price to more than $600 for an EpiPen two-pack. Mylan later announced plans to gell a generic version for $300.

Cigna, a top insurer, announced Wednesday that it was dropping coverage of the EpiPen and would cover only the half-priced generic.

A CVS Health spokeswoman said the price cut for the generic Adrenaclick was unrelated.

Adrenaclick and EpiPen give an emergency injection of epinephrine to treat life-threatening allergic reactions known as anaphylactic shock.

Also on Wednesday, President-elect Donald Trump vowed at a press conference to fight price hikes by drug companies, which he lambasted for “getting away with murder.” Mylan’s stock price dropped more than 4%.

30 Second Downloads

USDA recalls select frozen taquitos that may contain plastic

Volunteers needed to be advocates for Tarrant County kids in foster care

Dallas-based education developer donating app to help kids bridge learning gaps during pandemic

Don't Miss

Popular

Latest News

More News